Garri Zmudze
Overview
Garri Zmudze is a seasoned angel investor specializing in biotechnology and longevity sectors. He co-founded LongeVC, a venture capital firm supporting early-stage biotech and longevity-focused founders. He also co-founded Longenesis, a medical technology startup bridging healthcare institutions and the biotech industry to accelerate drug and treatment discovery. In 2021, Zmudze became a founding member of the Longevity Science Foundation, a global nonprofit funding research on extending healthy human lifespans. As an angel investor, he has backed companies like Insilico Medicine, Deep Longevity, and Basepaws, contributing to advancements in biotech and longevity. Zmudze is also a venture partner at PsyMed Ventures and advises organizations such as the Healthy Longevity Medicine Society and IoTeX. He serves on the boards of the Longevity Biotechnology Association and the Sheba Longevity Center, advocating for accessible biotech breakthroughs for people and their pets.
Investment Focus
- Innovative biotech and longevity-focused ventures
- Early-stage companies
- Global market potential
Portfolio Companies
Reach Garri Zmudze directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Garri Zmudze
What sectors does Garri Zmudze invest in?
Garri Zmudze invests in Healthcare, Biotechnology, Longevity, Pet Care and Veterinary Services, and is based in United States. Garri Zmudze is listed as a angel investor in the ConnectSafely investor database.
What stage does Garri Zmudze invest at?
Garri Zmudze backs companies at Seed and Series A, writing cheques of 500K - 1.5M.
Which regions does Garri Zmudze invest in?
Garri Zmudze invests across United States, Europe and Asia.
What companies has Garri Zmudze invested in?
Garri Zmudze's portfolio includes Insilico Medicine, Basepaws and Deep Longevity.
Last updated · Source: ConnectSafely investor database
